News

Natura Strengthens Commitment to Latin America Through Sale

Natura Strengthens Commitment to Latin America Through Sale

Natura Makes Strategic Move with Avon International Sale

SÃO PAULO - Natura has made a significant decision by entering an agreement to sell its Avon International business to Regent. This strategic move reflects Natura's commitment to consolidate its operations and prioritize its core market in Latin America. The agreement encompasses Avon's operations across various regions including Europe, Africa, and Asia, although it excludes Avon Russia, which remains classified separately.

Focus on Latin America

The sale reaffirms Natura's dedication to its Latin American operations. It aims to streamline its corporate structure while maintaining control of Avon’s brand and intellectual property rights within this key market. Natura has long regarded Latin America as central to its business model and strategic planning, which will not be altered by this transaction.

Completing Corporate Simplification

This agreement marks a pivotal point in Natura's ongoing corporate simplification journey, a process that began back in 2022. Fábio Barbosa, Chairman of Natura's Board of Directors, stated, "This agreement represents the final steps of the simplification journey initiated three years ago focused on the growth of our operations in Latin America." The Avon's International team was already adapting to a robust transformation agenda, and this evolution could potentially set the stage for sustained growth.

The Avon Legacy

With over 139 years of history, Avon is a name that resonates with many people around the globe. Michael Reinstein, Chairman of Regent, spoke about the profound impact Avon has had on the beauty industry, stating, "There are very few companies that have touched as many lives as Avon. The Avon Lady was the original influencer, pioneering social commerce long before the world had a name for it." This rich legacy serves as a backdrop against which the Avon brand continues to operate as the integration of Avon and Natura unfolds.

Continued Growth in Latin America

João Paulo Ferreira, CEO of Natura, highlighted that the operational integration of Avon and Natura within Latin America is expected to create meaningful efficiency gains. He stressed, "The ongoing work to reposition the Avon brand and to redefine its innovation portfolio gives us confidence that this brand will resume its growth in the region and help strengthen Natura's leadership in the Latin American markets." This optimism is borne from positive indicators arising from the integration efforts.

Recent Developments

Just days prior to this announcement, Natura disclosed the sale of Avon's assets in several Central American countries including Guatemala, Nicaragua, Panama, Honduras, El Salvador, and the Dominican Republic to Grupo PDC. This underscores Natura's proactive approach to focusing its operations on viable markets while facilitating a more concise organizational structure.

About Natura

Founded in 1969, Natura has established itself as a leading multinational beauty and personal care company. It has consistently ranked as Brazil's most reputable brand and has performed excellently in ESG ratings, holding this top position for 11 consecutive years. Natura is also recognized for its commitment to sustainability, particularly through partnerships with Amazonian extractive communities, benefiting thousands of families while conserving vast stretches of forest.

Innovative Practices

Since becoming the first publicly traded company to receive B Corp certification from B Lab in 2014, Natura has shown an unwavering dedication to marrying profitability with positive social and environmental impacts. The company maintains a vast network of over 3 million consultants across Latin America, complemented by its e-commerce platforms and physical retail presence.

About Regent

Regent, the acquiring company, is a prominent global holding firm engaged in multiple sectors, including technology, media, automotive, and consumer goods. Known for its recent acquisitions of notable brands like OESL and Petit Bateau, Regent has a diverse portfolio including luxury brands and technology-focused businesses.

Frequently Asked Questions

What was the main reason for Natura's sale of Avon International?

Natura's sale of Avon International is part of its strategy to streamline operations and enhance its focus on its Latin American market.

What does the sale mean for Avon in Latin America?

Avon’s operations in Latin America will remain under Natura’s control, ensuring the brand continues to thrive in this region.

How has Natura performed in recent years?

Natura has been recognized as Brazil's most reputable company and continues to achieve top performance in ESG rankings consistently.

What initiatives has Natura undertaken in sustainability?

Natura has initiated various sustainability efforts, including partnerships with Amazonian communities which benefit thousands and help conserve forest areas.

Who is Regent?

Regent is a global holding company that invests across various sectors, including consumer goods and technology, and recently expanded its portfolio through notable acquisitions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 106

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 99

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 227

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 203

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 211

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 155

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 138

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 136

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 193

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading

Top 5 Most Recently Viewed Articles

CNX Resources Reveals Third Quarter Results and Upcoming Call

Updated Category News Views 36

CNX Resources Corporation Financial Update CNX Resources Corporation (NYSE: CNX) is gearing up to announce its financial outcomes for the third quarter of 2024. This announcement is scheduled for 6:45 a.m. Eastern Time on a Thursday morning toward the end of October. During this time, CNX will also share essential materials, including remarks prepared for the quarter,...

Continue Reading
MBZUAI Enhances Research Collaboration with École Polytechnique

Updated Category News Views 183

Strengthening Research Cooperation Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) has officially expanded its strategic partnership with École Polytechnique, aiming for a more profound collaboration in artificial intelligence (AI) research. This new Collaborative Research Agreement is a significant step towards enhancing research capabilities in both...

Continue Reading
Projected Growth of Marine Collagen: Key Insights and Trends

Updated Category News Views 152

The Growing Marine Collagen Market The marine collagen market is set to experience significant growth in the coming years. As consumer awareness around health and beauty continues to rise, we see a shift in preference towards marine collagen, thanks to its impressive bioavailability and sustainable sourcing methods. Recent analyses reveal that this sector is predicted to...

Continue Reading
BioLife Solutions Prepares for Q1 2025 Financial Disclosure

Updated Category News Views 144

Exciting Financial Insights Awaiting from BioLife Solutions BioLife Solutions, Inc. (NASDAQ: BLFS) has announced that it will disclose its first quarter 2025 financial results, marking an important update for investors and stakeholders alike. This revelation is set to occur after the market closes, creating anticipation among those closely monitoring the company’s...

Continue Reading
FuboTV Achieves Record Subscriber Growth in North America

Updated Category News Views 174

FuboTV Reports Unprecedented Subscriber Growth FuboTV (NYSE: FUBO) has recently made headlines as it recorded the highest-ever growth in its North American subscriber base. This achievement highlights the company’s potential in the competitive streaming industry. The stock saw a notable increase on the day the company announced its earnings for the third quarter....

Continue Reading